Advertisement
Loading...

Evotec SE

EVOTF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$6.69
$0.00(0.00%)
U.S. Market is Open • 14:54
Advertisement

Evotec SE (EVOTF) Stock Overview

Explore Evotec SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-5.25
EPS (TTM)$-1.27
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$5.34
3 Months$6.89
1 Year Target$6.34

EVOTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Evotec SE (EVOTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 85.77, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $6.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.25 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
27.67%
3-Month Change
-16.48%
6-Month Change
-16.48%
Year-to-Date (YTD) Change
-16.48%
1-Year Change
-19.11%
3-Year Change
-68.40%
5-Year Change
-84.51%
All-Time (Max) Change
85.83%

Contact Information

https://www.evotec.com
49 40 560 81 0
Essener Bogen 7, Hamburg, NaN, 22419

Company Facts

4,766 Employees
IPO DateOct 7, 2009
CountryDE
Actively Trading

Frequently Asked Questions